Why pharmacovigilance and regulatory affairs are the smartest first jobs in pharma
If you are a B.Pharm, B.Sc, or M.Pharm graduate looking to enter the pharmaceutical industry in 2026, pharmacovigilance and regulatory affairs together offer the most consistent, scalable career path available right now.
The reasons are structural. Every drug sold globally must be monitored for safety throughout its lifecycle—from first-in-human trials to decades after market launch—and every one of those drugs must first be approved by regulators and then kept compliant for its entire commercial life. Indian pharma exports are growing, large CROs are expanding their PV and regulatory operations in Pune, and regulators worldwide are tightening safety reporting timelines and submission standards. The result: a permanent, growing demand for professionals trained in both drug safety and regulatory submissions, in a domain where your skills compound rapidly because the work is structured, regulated, and process-driven.
For Pune specifically, the opportunity is concentrated. The Hinjewadi-Wakad-Bhosari pharma corridor houses PV and regulatory operations for Cipla, Lupin, Mylan, Sun Pharma, Wockhardt, Glenmark, Emcure, and large CROs including Syngene, Veeda Clinical Research, Lambda Therapeutic Research, and Reliance Life Sciences. A professional in Pune who can handle both ICSR processing and regulatory dossiers is hired faster, paid better, and has more lateral movement than almost any other entry-level pharma role.
What you will actually do as a PV professional
Pharmacovigilance is often misunderstood. It is not lab-based, and it does not require a PhD. The day-to-day work centers on three activities:
Individual Case Safety Reports (ICSRs). Every adverse event reported about a drug—from a clinical trial, a hospital, a healthcare professional, or a patient—must be processed into a standardized report and submitted to regulators within tight timelines (often 7 or 15 calendar days). You receive the case, code the medical terms, write a clinical narrative, assess causality, and submit electronically.
Aggregate reports. Periodically, all the cases for a drug get rolled up into PSURs, PBRERs, or DSURs—long, detailed safety reviews submitted to regulators. As you grow, you write and review these.
Signal detection. When a new adverse event pattern emerges, statisticians and PV scientists investigate whether it represents a real safety risk requiring label changes or even drug withdrawal. This is the most analytical part of the field, and the highest-paid.
You work in a global drug safety database—Oracle Argus at most large pharma, ARISg at mid-sized CROs, increasingly Veeva Vault Safety at modern biotech, with ABcube at a growing set of mid-market companies. Our course gives you hands-on time on Argus, ARISg and ABcube plus a Veeva Vault Safety overview, so you walk into any employer ready.
The regulatory affairs half: getting drugs approved and keeping them compliant
Regulatory affairs is the discipline of getting drugs approved and keeping them on the market—the bridge between the science of drug development and the laws that govern its marketing. It sits at the same regulatory interface as pharmacovigilance, which is exactly why the two are taught together in this programme: a safety signal can trigger a label variation, a periodic safety report feeds a renewal dossier, and Risk Management Plans straddle both functions. Understanding both makes you far more useful to a Pune pharma or CRO team than a single-track specialist.
The regulatory half of the course covers the work as it is actually practised:
The Indian regulatory framework. CDSCO and DCGI structure, the SUGAM portal, the Drugs and Cosmetics Act, and the New Drugs and Clinical Trials Rules 2019—the practical workflow for an Indian generics filing.
Global submissions. USFDA (21 CFR; IND, NDA, ANDA, BLA, and 505(b)(2) pathways) and European procedures (EMA centralised vs decentralised, MHRA post-Brexit), and the strategic differences that drive market-by-market decisions.
CTD, eCTD, and dossier compilation. The heart of regulatory work—compiling Module 1, reviewing Modules 2–5, and managing the eCTD lifecycle (initial submission, supplements, variations) with sequence numbering, validation, and hyperlink management. You get hands-on with a sample dossier and industry tools like Lorenz docuBridge and GlobalSubmit.
Labelling and post-marketing compliance. Label and package-insert updates, post-approval change management, deficiency-letter and Form 483 responses, product renewal, and the ongoing lifecycle work where most regulatory professionals spend the bulk of their time.
How this course is structured
The 3-month program is built around how PV and regulatory affairs are actually practiced in industry, not how they are taught in academic textbooks.
The early weeks build foundations across both disciplines: regulatory framework, terminology, the ICSR lifecycle, and MedDRA coding. The middle weeks are hands-on—you process real anonymized cases in Argus, ARISg and ABcube under faculty supervision, exactly the way you would in your first job, and compile sections of a sample CTD/eCTD dossier. The final weeks cover aggregate reporting, signal detection, post-marketing compliance and lifecycle management, and intensive placement preparation.
Faculty are practicing PV and regulatory professionals, not academic instructors. The lead curriculum designer has 10+ years across Pune CROs and currently consults for pharmacovigilance system audits. Module instructors are senior PV scientists, ICSR processors, eCTD publishing specialists, and regulatory affairs team leads from Pune’s pharma corridor. You learn from people who close cases and file dossiers every day.
Placement infrastructure
Most clinical research institutes treat placement as an afterthought—a notice board, a placement officer, and a hope. We treat it as the deliverable.
Every student completes structured placement preparation in the final month: resume review against PV- and regulatory-specific criteria, three rounds of mock interviews with hiring managers from partner companies, and direct introductions to our 50+ pharma and CRO partners. Most placements happen via warm referral within 30–60 days of course completion.
We provide 100% placement assistance support for every student, with starting CTCs ranging from ₹3.5 LPA (case processor and regulatory trainee roles at CROs) to ₹6+ LPA (specialized roles for M.Pharm graduates with prior internship experience).
Who this course is right for
You will get the most out of this program if you are:
- A fresh graduate (B.Pharm, M.Pharm, B.Sc, M.Sc, BDS, BHMS) looking for a structured first job in pharma
- A working professional in adjacent fields (medical writing, clinical research, QA, production) wanting to add PV and regulatory affairs to your skillset
- Someone returning to work after a break who wants a remote-friendly, process-driven role
- A career-switcher from healthcare (nursing, paramedical) with a relevant qualification
You may not be the right fit if you are looking for a research-oriented or wet-lab career, or if you cannot commit to the full 3-month timeline.
Apply for the next batch
Batches start every quarter at our Wakad campus. Seats are limited to 24 per batch to maintain hands-on platform access and faculty attention. Early applications get priority for placement preparation and corporate partner introductions.
Reach out via WhatsApp for an immediate conversation about your background and the right intake batch for you.
Related courses
If you are still weighing this combined programme against adjacent clinical research paths, the closest alternatives are:
- Clinical Data Management — Office-based analytical alternative with similar entry CTC and strong remote-work options
- PG Diploma in Pharmacovigilance & Regulatory Affairs — 6-month comprehensive credential for deeper specialisation across both disciplines
- PG Diploma in Clinical Research — 6-month comprehensive credential if you want broader exposure before specialising
Further reading
- Pharmacovigilance Career Guide 2026: Salary, Scope & How to Get Started — salary by level, top Pune employers, and the four steps to your first PV job
- Pharmacovigilance vs CRA: A Detailed Comparison — decision framework with travel, salary, and temperament factors
- Pune Clinical Research Jobs 2026 — market report covering top 15 PV and regulatory employers in Pune
- Clinical Research After B.Pharm — all five entry paths compared